Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Aviragen Therapeutic (AVIR)

0 (0%)

Open:

Pre. Close:

High:

Low:

Volume:

Market Cap:

0M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

0.62 - 0.62

0.62 - 0.63

Low:

0.57 - 0.57

0.57 - 0.58

Close:

0.58 - 0.59

0.59 - 0.6

Technical analysis  (as of: 2017-12-14 4:50:33 PM)

Overall:

      

Stoxline rating system posted a NEUTRAL today, downgraded from higher rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 0.72     One year: 0.79

Support:

Support1: 0.52    Support2: 0.43

Resistance:

Resistance1: 0.62    Resistance2: 0.68

Pivot:

0.60

Moving Averages:

MA(5): 0.59     MA(20): 0.59

MA(100): 0.63     MA(250): 0.71

MACD:

MACD(12,26): -0.01     Signal(12,26,9): -0.01

%K %D:

%K(14,3): 33.31     %D(3): 30.76

RSI:

RSI(14): 46.66

52-Week:

High:   Low:   Change(%): -55.6

Average Vol(K):

3-Month: 96432  10-Days 17649

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
AVIR has closed above bottom band by 36.7%. Bollinger Bands are 46% narrower than normal. The narrow width of the bands suggests low volatility as compared to AVIR's normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Wed, 04 May 2016 01:46:26 GMT
Aviragen Therapeutics Inc.

Wed, 09 Nov 2016 21:00:00 GMT
Aviragen Therapeutics to Present at Stifel 2016 Healthcare Conference

Fri, 03 Feb 2017 02:15:00 GMT
Aviragen Therapeutics' (AVIR) CEO Joseph Patti on Q2 2017 Results - Earnings ...

Tue, 06 Sep 2016 22:30:00 GMT
Aviragen Therapeutics Announces Inducement Grant for New Employees

Wed, 27 Apr 2016 14:31:09 GMT
Biota Pharmaceuticals Is Now Aviragen Therapeutics

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

38.65

Shares Float (M)

31.64

% Held by Insiders

1.18

% Held by Institutions

40.25

Shares Short (K)

191

Shares Short Prior Month (K)

171

Stock Financials

EPS

-0.640

EPS Est. Current Year

-0.860

EPS Est. Next Year

-0.860

EPS Est. Next Quarter

-0.260

Forward EPS

-1.475

Book Value (p.s.)

0.360

PEG Ratio

Profit Margin

-277.53

Operating Margin

-255.06

Return on Assets (ttm)

-29.0

Return on Equity (ttm)

-97.8

Qtrly Rev. Growth

Gross Profit (p.s.)

0.230

Sales Per Share

EBITDA (p.s.)

-0.585

Qtrly Earnings Growth

Operating Cash Flow (M)

-23.80

Levered Free Cash Flow (M)

-12.51

atoplab.com

Valuation

P/E

-0.92

P/E Growth Ratio

-0.02

P/BV

1.64

P/S

99128856.00

P/CF

-0.96

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

2012-11-08

Ex-Dividend Date

2012-11-09

Forward Dividend

Last Split Date

2012-11-09

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.